Detall de l'activitat
XV Congrés de la Societat Catalana d’Immunologia
Societat Catalana d'Immunologia
25 i 26 de novembre de 2021 | Online | L'Acadèmia a Can Caralleu
Online
Online
Online
Dijous, 25 de novembre de 2021 | 16:00 - 20:00
Welcome to the XVth CONGRESS of the SCI > Online -
Presentador:
Pablo Engel Rocamora. Facultat de Medicina, Universitat de Barcelona
Opening Lecture: > Online -
Moderador:
Pablo Engel Rocamora. Facultat de Medicina, Universitat de Barcelona
Ponent:
Friedrich Koch-Nolte
Company sponsored session Becton Dickinson > Online -
Flow Cytometric Monitoring of Anti CD 20 Therapies
Ponent:
Bruno Brando
Plenary Session - Cord blood as a starting material for advanced therapies > Online -
Moderador:
Ramón Gimeno
Ponent:
Sergi Querol Giner
Oral Communications I Basic Experimental Immunology > Online -
Moderen:
Francisco Lozano Soto. President, Societat Catalana d’Immunologia
Jose Aramburu
OC1 IRF 1 is required for MDA 5 (IFIH 1 induction by IFN a, LPS and poly(I C) in murine macrophages Carlos
Ponent:
Carlos Batlle
OC 2 NK cells eliminate Epstein Barr virus bound to B cells through a specific antibody mediated uptake
Ponent:
Elisenda Alari
OC 3 Enforced sialyl Lewis X sLeX display in E selectin ligands by exofucosylation is dispensable for CD 19 CAR T cell activity and bone marrow homing.
Ponent:
Diego Sánchez
OC 4 HEK 293 F cell line shows different antigen presentation features than HEK 293
Ponent:
Alba Pastor
Divendres, 26 de novembre de 2021 | 09:00 - 19:45
Plenary Session - Advanced immunotherapies for the management of complications post hematopoietic stem cell transplant Multiple uses of mesenquimal cells > Online -
Moderador:
Francesc Rudilla
Ponent:
joaquim Vives Armengol
Oral Communications II Autoimmunity and Clinical Immunology > Online -
Moderen:
Clara Franco Jarava. Hospital Joan XXIII Tarragona
Odette Viñas
OC 5 Association of HLA B* 35 and severe hypersensitivity reactions secondary to benznidazole treatment in chronic Chagas disease patients.
Ponent:
Pau Bosch
OC 6 Limitations of commercial assays as diagnostic tests of autoimmune encephalitis.
Ponent:
Guillermo Muñoz
OC 7 Dacmecitos study Influence of the type of donation on the inflammatory pattern in lung transplantation.
Ponent:
Alberto Sandiumenge Camps. Hospital Universitari Vall d'Hebron
OC 8 Anti Th/To auto antibodies in patients with SSc are the commercial assays good enough?
Ponent:
Janire Perurena
OC 9 Interaction between humoral and cutaneous immune response to Candida albicans in plaque psoriasis.
Ponent:
Lídia Sans de San Nicolás
OC 10 Peripheral Blood Lymphocyte Subsets at diagnosis of Arthritis in the Elderly differences between elderly onset rheumatoid arthritis and polymyalgia rheumatic.
Ponent:
Aina Teniente Serra. Hospital Germans Trias
Plenary Session - Advanced immunotherapies for the management of complications post hematopoietic stem cell transplant Multiple uses of mesenquimal cells > Online -
Moderador:
Carles Serra
Ponent:
James Hutchinson
Company sponsored lunch session I Beckman Coulter > Online -
Ponent:
Michael Kapinsky
Unmasked Targets, Retired Pipettes, Uncharged Sorting And Other Beckman Coulter Innovations In Flow Cytometry
Company sponsored lunch session II Miltenyi Biotec > Online -
Ponent:
Daniel Schäfer
Identification of CAR target candidates against pancreatic adenocarcinoma using ultra high content imaging
Oral Communications III Tumor Immunology Immunotherapy > Online -
Moderen:
Alena Gros
Sonia Guedan
OC 11 MYC inhibition by an Omomyc based therapy abrogates tumor progression and induces immune cell recruitment in models of NSCLC.
Ponent:
Sílvia Casacuberta
OC 12 ARI 0001 autorització sota exempció Hospitalària com emprar productes d'immunoteràpia autoritzats després d'un assaig clínic exitòs.
Ponent:
Manel Juan Otero. Hospital Clínic Barcelona
OC 13 Optimizing a FAP CAR T cell for clinical trials.
Ponent:
Estela Ortega
OC 14 Pre leukemic CD 34 +CD 19 CD 22 early B cell progenitors might underlie phenotypic escape in patients treated with CD 19 directed immunotherapies.
Ponent:
Clara Bueno
OC 15 A novel and efficient tandem CD 19 and CD 22 directed CAR for B cell ALL.
Ponent:
Talia Velasco
OC 16 DIF peptides, a new approach to cancer immunotherapy Preliminary studies.
Ponent:
Marta Corral
OC 17 CD 137 costimulation counteracts TGF B inhibition of NK cell anti tumor function.
Ponent:
Aura Muntasell et
Oral Communications IV COVID 19 > Online -
Moderen:
Gemma Moncunill
Jorge Carrillo
OC 18 SARS CoV 2 sculpts the immune system to induce sustained virus specific naïve like and memory B cell responses.
Ponent:
Giuliana Magri
OC 19 Clinical course impacts early kinetics and long term magnitude and amplitude of SARS CoV 2 neutralizing antibodies beyond one year after infection.
Ponent:
Edwar Pradenas
OC 20 Determinants of early antibody responses to COVID 19 mRNA vaccines in exposed and naive healthcare workers.
Ponent:
Gemma Moncunill
OC 21 A new flow cytometry cell based assay to efficiently determine RBD specific neutralization of SARS CoV 2 emerging variants.
Ponent:
Pablo Hernández
OC 22 Analysis of Clinical and Laboratory Markers Based on the First COVID 19 Wave in Barcelona Limitations of the Current Clinicopathological Tests Guides the Identification of Effective Biomarkers.
Ponent:
Ricardo Pujol Borrell
OC 23 High dose intravenous immunoglobulins might modulate inflammation in COVID 19 patients.
Ponent:
Erola Ainsua
OC 24 SARS CoV 2 antibody kinetics in healthcare workers in northern metropolitan Barcelona.
Ponent:
Marc Boigues Pons
Plenary Session - Regulatory T cells in Autoimmune diseases > Online -
Moderador:
Eva Martínez Cáceres
Ponent:
Piotr Trzonzowski